Preview

Meditsinskiy sovet = Medical Council

Advanced search

Pityriasis versicolor: current state of the problem

https://doi.org/10.21518/ms2025-306

Abstract

Pityriasis versicolor (tinea versicolor) lichen (PVL) is a chronic superficial fungal infection of the skin caused by the proliferation of lipophilic yeast (Malassezia species) in the stratum corneum of the epidermis. Multicolored lichen is a disease that is widespread everywhere, but it is more common in those countries where the temperature and humidity are elevated. People of both young and old age are ill, the disease is also registered in children. The main causative agents of the so-called malasseziosis, which includes ringworm, are Malassezia sympodialis, Malassezia globosa, Malassezia furfur, Malassezia restricta. Mushrooms of the genus Malassezia are the only representatives of the kingdom of fungi that are commensals of normal human skin. Malassezia spp. – lipophilic fungus, therefore, the intensity of skin colonization is associated with the function of sebaceous glands, a change in the chemical composition of the fatty mantle. In the population, the incidence statistically depends on: age (peak incidence is at the age of 14–40 years); gender differences (men are 1.5–2 times more likely to get sick); the presence of concomitant diseases of the gastrointestinal tract, endocrine disorders, vegetative diseases, immunodeficiency of various etiologies; geographical latitude (in temperate climates – about 2%, in tropical – up to 40% of the total population); professional activity of patients (in persons engaged in physical labor, sweating profusely); hereditary predisposition. The skin of the chest and back is a favorite place of localization, less often the elements are noted on the skin of the neck, abdomen, lateral surfaces of the trunk, and the outer surface of the shoulders. In addition, rashes can be found on the scalp, but without hair damage, sometimes in the inguinal folds and axillary areas. According to the 2020 Clinical Guidelines of the Russian Federation for the treatment of multicolored lichen, external (topical therapy) is used for limited forms of the disease. The article presents our own clinical observations of the effectiveness of using the Russian-made drug Acrimicol (2% sertaconazole cream).

About the Authors

Ju. S. Kovaleva
Altay State Medical University
Russian Federation

Julia S. Kovaleva, Dr. Sci. (Med.), Head of the Department of Dermatovenereology, Cosmetology and Immunology

40, Lenin Ave., Barnaul, Altai Region, 656038



N. G. Komkina
Altay State Medical University
Russian Federation

Natalia G. Komkina, Cand. Sci. (Med.), Associate Professor of the Department of Dermatovenereology, Cosmetology and Immunology

40, Lenin Ave., Barnaul, Altai Region, 656038



O. A. Karpova
Russian Railways-Medicine Clinical Hospital of Barnaul
Russian Federation

Olga A. Karpova, Dermatovenerologist

20, Molodezhnaya St., 656038, Barnaul



References

1. Сергеев АЮ, Сергеев ЮВ. Грибковые инфекции. Руководство для врачей. 2-е изд. М.: БИНОМ; 2008. 480 с. Режим доступа: https://viewer.rsl.ru/ru/rsl01003502672.

2. Karakaş M, Turaç-Biçer A, Ilkit M, Durdu M, Seydaoğlu G. Epidemiology of pityriasis versicolor in Adana, Turkey. J Dermatol. 2009;36(7):377–382. https://doi.org/10.1111/j.1346-8138.2009.00663.x.

3. Morais PM, Cunha Mda G, Frota MZ. Clinical aspects of patients with pityriasis versicolor seen at a referral center for tropical dermatology in Manaus, Amazonas, Brazil. An Bras Dermatol. 2010;85(6):797–803. https://doi.org/10.1590/s0365-05962010000600004.

4. Ghosh SK, Dey SK, Saha I, Barbhuiya JN, Ghosh A, Roy AK. Pityriasis versicolor: a clinicomycological and epidemiological study from a tertiary care hospital. Indian J Dermatol. 2008;53(4):182–185. https://doi.org/10.4103/0019-5154.44791.

5. Giusiano G, Sosa Mde L, Rojas F, Vanacore ST, Mangiaterra M. Prevalence of Malassezia species in pityriasis versicolor lesions in northeast Argentina. Rev Iberoam Micol. 2010;27(2):71–74. https://doi.org/10.1016/j.riam.2009.12.005.

6. Salahi-Moghaddam A, Davoodian P, Jafari A, Nikoo MA. Evaluation of pityriasis versicolor in prisoners: a cross-sectional study. Indian J Dermatol Venereol Leprol. 2009;75(4):379–382. https://doi.org/10.4103/0378-6323.53134.

7. Кутасевич ЯФ, Олійник ІО, Білозоров ОП, П’ятикоп ІО, Матюшенко ВП. On the question of atypical forms of mycosis smooth skin. Дерматологiя та венерологiя. 2015;4(70):96–101. (In Russ.) Available at: https://www.elibrary.ru/tlbxeh.

8. Framil VM, Melhem MS, Szeszs MW, Zaitz C. New aspects in the clinical course of pityriasis versicolor. An Bras Dermatol. 2011;86(6):1135–1140. https://doi.org/10.1590/s0365-05962011000600011.

9. Takha TV, Nazhmutdinova DK. The use of antimycotic drugs in the treatment of pityriasis. RMJ. 2009;17:1072. (In Russ.) Available at: https://www.rmj.ru/articles/dermatologiya/Ispolyzovanie_antimikoticheskih_preparatov__v_lechenii_otrubevidnogo_lishaya/?ysclid=m6gh1e1xu4349254362.

10. Иванов ОЛ (ред.). Кожные и венерические болезни: Справочник. М.: Медицина; 1997. 352 с. Режим доступа: https://search.rsl.ru/ru/record/01001772432?ysclid=md5lr6g43m663012252.

11. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002;15(4):545–563. https://doi.org/10.1128/CMR.15.4.545-563.2002.

12. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000;38(5):337–341. https://doi.org/10.1080/mmy.38.5.337.341.

13. Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis. 2006;19(2):139–147. https://doi.org/10.1097/01.qco.0000216624.21069.61.

14. Aspiroz C, Moreno LA, Rezusta A, Rubio C. Differentiation of three biotypes of Malassezia species on human normal skin. correspondence with M. globosa, M. sympodialis and M. restricta. Mycopathologia. 1999;145(2):69–674. https://doi.org/10.1023/a:1007017917230.

15. Mayser P, Gross A. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm Venereol. 2000;80(5):357–361. https://doi.org/10.1080/000155500459303.

16. Tarazooie B, Kordbacheh P, Zaini F, Zomorodian K, Saadat F, Zeraati H et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol. 2004;4:5. https://doi.org/10.1186/1471-5945-4-5.

17. Хэбиф ТП. Кожные болезни: Диагностика и лечение. 3-е изд. М.: МЕДпресс-информ; 2008. 672 с.

18. Яковлев АБ, Суворова КН. Малассезия – инфекция кожи человека. М.: РМАПО; 2007. 40 с. Режим доступа: https://search.rsl.ru/ru/record/01003143237?ysclid=md4k9m8rvr648602671.

19. Тимофеева ЕР (ред.). Дерматология. Атлас-справочник. М.: Практика; 1999. 1044 с. Режим доступа: https://search.rsl.ru/ru/record/01000691979?ysclid=md4kajkkem836159704.

20. Климко НН. Микозы: диагностика и лечение. 2-е изд. М.: Ви Джи Групп; 2008. 114 с. Режим доступа: https://search.rsl.ru/ru/record/01004099713?ysclid=md5mbk8wjx127212960.

21. Abdulloeva MA, Zoirov PT. Clinical forms of pityriasis versicolor. Zdravoohranenie Tadžikistana. 2011;4(311):12–15. (In Russ.) Available at: https://www.elibrary.ru/papgmb.

22. Yakovlev AB. Features of clinic of superficial mycosises at children’s age. Practical Medicine. 2009;5(37):47–55. (In Russ.) Available at: https://pmarchive.ru/osobennosti-kliniki-poverxnostnyx-mikozov-v-detskom-vozraste.

23. Chernova VA, Ustinov MV. Multicolored lichen: the possibilities of using shampoo containing ketoconazole and zinc pyrithione. RMJ. 2015;(19):1175–1178. (In Russ.) Available at: https://www.rmj.ru/articles/dermatologiya/Raznocvetnyy_lishay_vozmoghnosti_primeneniya_shampunya_soderghaschego_ketokonazol_i_cinka_pirition/?ysclid=m6gimcrn23524646184.

24. Gallyamova YuA. Pityriasis. Lechaschi Vrach. 2010;(5):38. (In Russ.) Available at: https://www.lvrach.ru/2010/05/13768326.

25. Тарасенко ГН, Тарасенко ЮГ. Основы практической микологии. М.: ОАЗИС-Дизайн; 2008. 154 c.

26. Matushevskaya EV, Ivanova MA, Shevchenko AG, Svirshchevskaya EV. Clinical and epidemiological aspects and modern approaches to the treatment of pityriasis versicolor. Meditsinskiy Sovet. 2024;(13):57–66. (In Russ.) https://doi.org/10.21518/ms2024-328.

27. Аравийский РА, Климко НН, Васильев НВ. Диагностика микозов. СПб.: Издательский дом СПбМАПО; 2004. 185 c. Режим доступа: https://n.eruditor.one/file/3549566.

28. Kaur I, Jakhar D, Singal A. Dermoscopy in the Evaluation of Pityriasis Versicolor: A Cross Sectional Study. Indian Dermatol Online J. 2019;10(6):682–685. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6859761.

29. Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL Jr. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018;56(Suppl. 1):S10-S25. https://doi.org/10.1093/mmy/myx134.

30. Утц СР. Федеральные клинические рекомендации по ведению больных разноцветным лишаем. 2015. Режим доступа: https://diseases.medelement.com/disease/%D1%80%D0%B0%D0%B7%D0%BD%D0%BE%D1%86%D0%B2%D0%B5%D1%82%D0%BD%D1%8B%D0%B9-%D0%BB%D0%B8%D1%88%D0%B0%D0%B9-%D1%80%D0%B5%D0%BA%D0%BE%D0%BC%D0%B5%D0%BD%D0%B4%D0%B0%D1%86%D0%B8%D0%B8-%D1%80%D1%84/15253.

31. Силина ЛВ. Оценка эффективности применения сертаконазола крема в терапии разноцветного лишая. В: Сергеев ЮВ (ред.). Успехи медицинской микологии: материалы Международного микологического форума. Москва, 22–23 мая 2024 г. М.: Национальная академия микологии; 2024. С. 118–120.

32. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration: results of a human in vivo study. Arzneimittel Forschung Drug Res. 2000;50:659–663. https://doi.org/10.1055/s-0031-1300268.

33. Baschong W, Hüglin D, Röding J. D-Panthenol loaded nanotypes™ providing enhanced anti-inflammatory efficacy: a study on human volunteers. Seifen Öle Fette Wachse J. 1999;125:29–30.

34. Bielfeldt S, Wehmeyer A, Rippke F. Efficacy of a new hand care system (cleansing oil and cream) in a model of irritation and in atopic hand eczema. Derm Beruf Umwelt. 1998;46:159–165.

35. Bahmer F, Pigatto P, Wehmeyer A. Adjuvante Hautpflege mit den dexpanthenolhaltigen Formen von pH5-Eucerin. Dt Derm. 1998;4:366–373.

36. Radtke MA, Lee-Seifert C, Rustenbach SJ, Schäfer I, Augustin M. Efficacy and patient benefit of treatment of irritated skin with ointments containing dexpanthenol: health services research (observational study) on self-medication in a pharmaceutical network. Hautarzt. 2009;60(5):414–419. https://doi.org/10.1007/s00105-009-1729-x.

37. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration: results of a human in vivo study. Arzneimittel Forschung Drug Res. 2000;50:659–663. Available at: https://pubmed.ncbi.nlm.nih.gov/10965426.


Review

For citations:


Kovaleva JS, Komkina NG, Karpova OA. Pityriasis versicolor: current state of the problem. Meditsinskiy sovet = Medical Council. (In Russ.) https://doi.org/10.21518/ms2025-306

Views: 29


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)